Overlooked value — what the screen found 2026-09-25
Among the 35 companies passing today’s screen for "Overlooked value", Fortress Biotech (FBIO) stands out with a trailing P/E of just 0.55. This strikingly low valuation places FBIO near the bottom of the pack, which has a median trailing…
Key figures
Data as of Sep 25, 2026- FBIO (Fortress Biotech, Inc.) market cap
- $78.21M
- BYND (Beyond Meat, Inc. Common Stock) market cap
- $171.77M
- GLIBA (Liberty Capital Corporation Series A GCI Group Common Stock) market cap
- $942.96M
- PXLW (Pixelworks Inc) market cap
- $43.62M
- COHN (Cohen & Company Inc) market cap
- $32.77M
- ELUT market cap
- $37.65M
Among the 35 companies passing today’s screen for "Overlooked value"¹, Fortress Biotech (FBIO) stands out with a trailing P/E of just 0.55². This strikingly low valuation places FBIO near the bottom of the pack, which has a median trailing P/E of 2.24³ and ranges from 0.55 to 5.37⁴.
Beyond Meat (BYND) is another notable mention with a trailing P/E of 0.59⁵. BYND, like FBIO, operates in the manufacturing sector but boasts a larger market cap at $171.77M compared to FBIO's $78.21M⁶⁷.
Liberty Capital Corporation Series A (GLIBA) has a trailing P/E of 0.62 and a market cap of $942.96M, significantly higher than the others mentioned here⁸⁹. Pixelworks Inc (PXLW) also makes the list with a trailing P/E of 0.63 and a market cap of $43.62M¹⁰.
However, passing this screen does not establish that these companies are necessarily good buys or poised for growth. The low valuations could indicate undervaluation, but they might also signal underlying issues that analysts have yet to cover comprehensively. Given the thin coverage, investors must do their due diligence before considering an investment in these names.
It is important to note that this screen is a filter based on specific criteria and does not guarantee future performance or investment success.
Educational tool. Not investment advice. This article was produced with automated assistance and reviewed before publishing.